What is a Stem Cell?

Welcome To The Neocardiogenesis™

According to Harold Varmus, a Nobel Prize winner and the former NIH director: "The development of cell lines that may produce almost every tissue of the human body is an unprecedented scientific breakthrough. It is not too unrealistic to say that this research has the potential to revolutionize the practice of medicine and improve the quality of life."

Can Stem Cells Save Dying Hearts?

The facts are clear: the stem cell is set to dominate the popular awareness of science.

No branch of science has grown more rapidly or produced more dramatic results than biomedicine: the biggest excitement swirled around the potential for the ultimate solution for personal medicine: an unlimited supply of replacement parts cloned from the patient’s own cells.

The Neocardiogenesistm Project

The most powerful and potent therapy that has ever been developed for patients affected by cardiovascular disease, uses adult stem cells from the patient’s own bodies. It promises to be better than all the best drugs and interventional surgical therapies and is a godsend for the desperate and dying.

Heart disease, as we all know is the most prolific medical killer, affecting a reported 50 million individuals in the U.S. alone. Interventional cardiology and open-heart surgery is the number one moneymaker for hospitals. 

Heart Disease And Stroke Cost America Nearly $1 Billion A Day In Medical Costs, Lost Productivity

By 2030, annual direct medical costs associated with cardiovascular diseases are projected to rise to more than $818 billion, while lost productivity costs could exceed $275 billion.

Remember: It is not a question of if you will need these stem cells, but a question of when. Imagine for one moment, that there were a new, powerful; non-invasive and completely safe procedure for even the most severe cases of heart disease. In addition, this miracle cure could actually restore the hearts ability to pump, and actually rebuild the destroyed and damaged heart tissue; muscle; and blood vessels. Is this truly possible? And if true, more importantly, why have we not heard of this before?

Economics of bypass surgery

1. Average cost of minimal intervention; $65,000.

2.      Cost of multiple grafts; $150,000.

3.      Complicated procedures; $300,000.

4.      In addition, the additional costs of hospital stays; pacemakers; defibrillators; and subsequent procedures.

5.      Moreover, the expense of top of the line medications for 30 years.

It has been estimated that total costs over the lifetime of each critically ill patient with seemingly never-ending recurrent events is approximately one-million dollars.

Compare this to the colossal impact of stem cell therapy, where, a typically, one –time cell transplant can potentially rebuild the heart and eventually clear the arteries and normalize the lives of heart failure patients. Can this really be the future of cardiology? Today however, the best doctor-scientists are pushing stem cell cardiology ahead at an incredible speed. At a recent annual American Heart Association conference, 25% of the 150 presentations were about this new powerful therapy. The FDA has formed a special new panel; CBER or Center for Biologics Evaluation and Research to review and evaluate this break through medical technology. The Cardiovascular Research Foundation (CRF) sponsors an international stem cell conference at Columbia University. The National Institute of Health (NIH) is creating a special Cardiovascular Cell Therapy Trials Network.


No Comments Yet.

Leave a comment